Clinical Trials List
Protocol NumberZN-c3-020
Not yet recruiting
2026-05-01 - 2029-12-31
Phase III
Recruiting2
-
Trial Applicant
MEDPACE TAIWAN LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/06/01
Investigators and Locations
Co-Principal Investigator
- 王韶靖 Division of Obstetrics & Gynecology
- 范鈞婷 Division of Obstetrics & Gynecology
- 黃曉峰 Division of Obstetrics & Gynecology
- 石宇翔 Division of Obstetrics & Gynecology
- 孫珞 Division of Obstetrics & Gynecology
- 詹松儒 Division of Radiology
- 呂亭芳 Division of Obstetrics & Gynecology
- 許世典 Division of Obstetrics & Gynecology
- 劉芝谷 Division of Obstetrics & Gynecology
- 陳彥甫 Division of Obstetrics & Gynecology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
50 participants
-
Global
420 participants
